Skip to content
CompanySight
Company No. 01729064 · Incorporated 3 Jun 1983

DR Reddy's Laboratories (UK) Limited

Registered name: DR REDDY'S LABORATORIES (UK) LIMITED

Part of Dr Reddy's Labs Sa group

DR Reddy's Laboratories (UK) Limited made £95m revenue and £10.1m profit in the year to 31 Mar 2026.

DR Reddy's Laboratories (UK) Limited’s revenue grew 41% to £95m in the year to 31 Mar 2026, with £10.1m profit and 46 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Cambridge; we hold 4 years of its filed accounts.

Full profit & loss filedSection C · ManufacturingSIC 21200Manufacture of pharmaceutical preparations
Status
Active
Location
Cambridge, East of England
Age
43 yrs · since 1983
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2026

Key figures

Capital-lightOperating leverage
Revenue
£95m
Growth ▲41%
Profit
£10.1m
Growth ▲74.1%
Profit margin
10.6%
Gross 25.6%
Employees
46
Change ▲15%
Profit / employee
£220k
Revenue/employee £2.1m
Profitable streak
4yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 202331 Mar 202431 Mar 202531 Mar 2026
DisclosureProfit & lossProfit & lossProfit & lossProfit & loss
Profit & loss
Revenue (turnover)£49.1m£60.8m£67.4m£95m
Cost of sales£36.2m£45.8m£50.4m£70.7m
Gross profit£12.9m£15m£17m£24.3m
Operating profit£6.1m£15.4m£5.4m£9m
Profit before tax£6.5m£17.8m£7.1m£10.3m
Profit after tax£5.8m£13.3m£5.8m£10.1m
Profit (best available)£5.8m£13.3m£5.8m£10.1m
Staff costs£3.4m£3.2m£5.5m£5.8m
Employees (average)39364046
Ratios
Profit margin11.8%21.9%8.6%10.6%
Gross margin26.3%24.7%25.3%25.6%
Revenue per employee£1.3m£1.7m£1.7m£2.1m
Profit per employee£149k£370k£145k£220k
Growth (year on year)
Revenue growth—▲23.9%▲10.8%▲41%
Profit growth—▲129.1%▼56.4%▲74.1%
Headcount growth—▼7.7%▲11.1%▲15%
Balance sheet — indirect signals, not revenue
Cash at bank£700k£1.4m£1.4m£719k
Net assets£42.9m£56.2m£52m£62.1m
Fixed assets£533k£1.1m£615k£602k
Current assets£63.3m£77.6m£70.8m£89.9m
Debtors£13.4m£12.3m£20.6m£27.3m
SourceFullAccounts · bulk data May 2024FullAccounts · bulk data May 2024FullAccounts · bulk data May 2025FullAccounts · bulk data May 2026
Derived from the latest filing

How the business works

Profit margin
10.6%
Profit ÷ revenue.
Gross margin
25.6%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£2.1m
Revenue ÷ average employees.
Profit per employee
£220k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
0.6%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
28.7%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲19%
Now £62.1m
Cash at bank
▼47%
Now £719k
Headcount
▲15%
Now 46
Deferred income
—
Now —
Fixed assets
▼2%
Now £602k
Corporate ownership

Group structure

Ownership chain

  1. Dr Reddy's Labs Sa (registered outside the UK register)ultimate parent75–100%
  2. DR. Reddy's Laboratories (EU) Limited75–100%
  3. DR Reddy's Laboratories (UK) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Mar 2026 (profit £10.1m), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.

Updated from Companies House on 24 Oct 2026